Wellington Management Group LLP increased its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 291.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 291,682 shares of the real estate investment trust's stock after purchasing an additional 217,168 shares during the quarter. Wellington Management Group LLP owned approximately 0.11% of Omega Healthcare Investors worth $11,871,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also recently added to or reduced their stakes in the company. State Street Corp increased its holdings in shares of Omega Healthcare Investors by 0.9% during the 3rd quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust's stock worth $502,228,000 after buying an additional 114,085 shares during the last quarter. Quantinno Capital Management LP boosted its holdings in Omega Healthcare Investors by 81.9% in the third quarter. Quantinno Capital Management LP now owns 106,464 shares of the real estate investment trust's stock valued at $4,333,000 after purchasing an additional 47,931 shares during the last quarter. Quarry LP acquired a new stake in Omega Healthcare Investors in the third quarter valued at $70,000. Parallax Volatility Advisers L.P. increased its holdings in Omega Healthcare Investors by 115.9% in the third quarter. Parallax Volatility Advisers L.P. now owns 34,982 shares of the real estate investment trust's stock valued at $1,424,000 after buying an additional 254,471 shares during the last quarter. Finally, IHT Wealth Management LLC boosted its holdings in shares of Omega Healthcare Investors by 86.9% in the 3rd quarter. IHT Wealth Management LLC now owns 13,436 shares of the real estate investment trust's stock valued at $545,000 after buying an additional 6,246 shares during the period. Institutional investors and hedge funds own 65.25% of the company's stock.
Omega Healthcare Investors Stock Performance
Shares of NYSE:OHI traded up $0.41 on Friday, hitting $39.21. The company had a trading volume of 1,655,830 shares, compared to its average volume of 1,687,985. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. The stock has a 50 day moving average price of $40.38 and a 200 day moving average price of $37.92. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42. The stock has a market cap of $10.58 billion, a price-to-earnings ratio of 28.83, a P/E/G ratio of 1.21 and a beta of 0.98.
Omega Healthcare Investors Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.83%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors's payout ratio is 197.06%.
Insider Activity at Omega Healthcare Investors
In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the business's stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares of the company's stock, valued at $4,025,000. The trade was a 36.19 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This trade represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on the company. Berenberg Bank started coverage on Omega Healthcare Investors in a report on Friday, October 18th. They set a "buy" rating and a $45.00 price target on the stock. Royal Bank of Canada upped their target price on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a "sector perform" rating in a report on Monday, November 11th. BMO Capital Markets upgraded shares of Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 price objective on the stock in a research report on Monday, December 9th. Wells Fargo & Company restated an "overweight" rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Finally, Truist Financial raised their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a report on Wednesday, September 4th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $40.18.
Check Out Our Latest Report on OHI
About Omega Healthcare Investors
(
Free Report)
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Read More
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.